Clinical trial Recruiting at 1 site Observational Ages 65 to 85

Heart Rate Variability Changes and Delirium After Major Abdominal Surgery

Official title: Predictive Value of Early Postoperative Heart Rate Variability Changes From Baseline for Postoperative Delirium in Older Adults Undergoing Major Abdominal Surgery: A Prospective Cohort Study

Run by The First Affiliated Hospital with Nanjing Medical University · NCT07783464 · Data updated 2026-11-12

This study looks at whether early changes in resting heart rate variability can signal the development of postoperative delirium in older adults after major abdominal surgery.

Quick facts

Study typeObservational
Ages65 Years to 85 Years
SexAll
Enrollment500 (estimated)
SponsorThe First Affiliated Hospital with Nanjing Medical University
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedSeptember 21, 2026
Main results expectedApril 30, 2027
Study endsMay 15, 2027
Registry record updatedSeptember 28, 2026
Trial IDNCT07783464 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Older adults aged 65–85 undergoing elective major abdominal surgery with general anesthesia, able to consent and comply with HRV measurements.

Probably not a fit

Patients with more severe comorbidity or conditions affecting HRV who do not develop POD may not see a direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective observational study enrolling adults aged 65–85 undergoing elective major abdominal surgery under general anesthesia. Resting HRV will be measured before anesthesia and on postoperative day 1 using 5-minute recordings, with analysis across time-domain and frequency-domain metrics. Postoperative delirium will be tracked daily from 24 hours after surgery through day 7 using the 3D-CAM. Researchers will explore whether changes in HRV from baseline are associated with POD and consider HRV-derived markers as potential early indicators. The study aims to improve understanding of autonomic biomarkers for POD risk in elderly surgical patients.

Why it matters

Potential benefit: If successful, HRV changes could become an early, non-invasive marker to identify patients at risk for POD, enabling closer monitoring or preventive strategies.

How similar studies have gone: Previous research suggests HRV is related to stress responses, but direct associations with POD have been exploratory and this study adds prospective, standardized measurement.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Patients admitted to Jiangsu Provincial People's Hospital who are scheduled to undergo elective major abdominal surgery under general anesthesia.
2. Older patients aged 65 to 85 years.
3. Expected postoperative hospital stay of ≥7 days.
4. Body mass index (BMI) between 18.5 and 28.0 kg/m².
5. American Society of Anesthesiologists (ASA) physical status classification I-III.
6. Patients who are conscious, mentally competent, and able to cooperate with heart rate variability (HRV) measurements, questionnaire assessments, and follow-up evaluations.
7. Patients who voluntarily participate in the study and provide written informed consent.

Exclusion Criteria

1. Patients with ASA physical status classification ≥IV or patients with end-stage cancer.
2. Patients with implanted cardiac pacemakers, implantable cardioverter-defibrillators, or other electronic devices that may interfere with ECG signal acquisition.
3. Patients with severe or unstable cardiovascular diseases, including but not limited to acute coronary syndrome, symptomatic bradycardia, sick sinus syndrome, second-degree or higher atrioventricular block, atrial fibrillation, atrial flutter, frequent premature beats, or other arrhythmias that may affect heart rate variability analysis.
4. Patients with diseases affecting autonomic nervous system function, including confirmed primary or secondary autonomic dysfunction, such as Parkinson's disease, multiple system atrophy, severe diabetic autonomic neuropathy, severe peripheral neuropathy, poorly controlled hyperthyroidism or hypothyroidism, and systemic amyloidosis.
5. Patients with a history of organic central nervous system diseases or psychiatric disorders, including major traumatic brain injury, stroke (ischemic or hemorrhagic), intracranial mass lesions, epilepsy, schizophrenia, bipolar disorder, major depressive disorder, or other severe psychiatric disorders.
6. Patients with severe baseline cognitive impairment or inability to complete cognitive assessments, including any of the following: (1) preoperative baseline Montreal Cognitive Assessment (MoCA) score \<14 points; (2) previously diagnosed dementia, preoperative delirium, coma, or other severe disturbances of consciousness; or (3) inability to complete standardized cognitive assessments due to severe visual impairment, hearing impairment, language barriers, or other causes.
7. Patients unable to undergo HRV measurement within 24 hours after surgery, including those with severe perioperative complications, emergency reoperation, extremely unstable vital signs, or requiring continuous deep sedation after surgery.
8. Patients who have taken anticholinergic medications, beta-blockers, antiarrhythmic drugs, or other medications that may significantly affect autonomic function within 1 month before study enrollment.
9. Patients who are currently participating in any other clinical trial.

Where it's running

  • The First Affiliated Hospital with Nanjing Medical University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.